Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years-Reference-Cited by-同舟云学术

Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years

Published:1999-04 Issue:4 Volume:53 Page:690-695
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Hudson Perry B.,Boake Rex,Trachtenberg John,Romas Nicholas A.,Rosenblatt Sidney,Narayan Perinchery,Geller Jack,Lieber Michael M.,Elhilali Mostafa,Norman Richard,Patterson Lynn,Perreault Jean-Paul,Malek Gholam H.,Bruskewitz Reginald C.,Roy Johnny B.,Ko Amy,Jacobsen Carol A.,Stoner Elizabeth

Publisher

Elsevier BV

Subject

Urology

Reference15 articles.

1. The effect of finasteride in men with benign prostatic hyperplasia;Gormley;N Engl J Med,1992

2. The American Urological Association Symptom Index for benign prostatic hyperplasia;Barry;J Urol,1992

3. A new look at bladder neck obstruction by the Food and Drug Administration regulators;Boyarsky;Trans Am Assoc Genito-Urin Surg,1977

4. Validation of a symptoms questionnaire for benign prostatic hyperplasia;Bolognese;Prostate,1992

5. Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride;Boyle;Urology,1996

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer;Asian Journal of Urology;2020-07

2. Post-finasteride syndrome: a surmountable challenge for clinicians;Fertility and Sterility;2020-01

3. Targeting 5α-reductase with 99mTc labeled dutasteride derivatives for prostate imaging;Radiochimica Acta;2019-09-13

4. Clinical Course of the Benign Prostate Hyplasia Patients during the Intermittent Use of 5-Alpha Reductase Inhibitors;Urogenital Tract Infection;2019

5. The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption;Current Sexual Health Reports;2018-07-27